Literature DB >> 26380610

Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma.

.   

Abstract

Entities:  

Year:  2015        PMID: 26380610      PMCID: PMC4570062     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN: 1942-2962


× No keyword cloud information.
  1 in total

1.  Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.

Authors:  Wyndham H Wilson; Ryan M Young; Roland Schmitz; Yandan Yang; Stefania Pittaluga; George Wright; Chih-Jian Lih; P Mickey Williams; Arthur L Shaffer; John Gerecitano; Sven de Vos; Andre Goy; Vaishalee P Kenkre; Paul M Barr; Kristie A Blum; Andrei Shustov; Ranjana Advani; Nathan H Fowler; Julie M Vose; Rebecca L Elstrom; Thomas M Habermann; Jacqueline C Barrientos; Jesse McGreivy; Maria Fardis; Betty Y Chang; Fong Clow; Brian Munneke; Davina Moussa; Darrin M Beaupre; Louis M Staudt
Journal:  Nat Med       Date:  2015-07-20       Impact factor: 53.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.